Tivic Health Systems, Inc. operates as a late-stage immunotherapeutics company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company’s pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications. In addition, it offers CDMO services. The company was incorporated in 2016 and is based in San Antonio, Texas.
The current price of TIVC is $0.49 USD — it has increased by +68.47% in the past 24 hours. Watch Tivic Health Systems stock price performance more closely on the chart.
What is Tivic Health Systems stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Tivic Health Systems stocks are traded under the ticker TIVC.
Is Tivic Health Systems stock price growing?▼
TIVC stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Tivic Health Systems has showed a -83.22% decrease.
What is Tivic Health Systems market cap?▼
Today Tivic Health Systems has the market capitalization of 2.03M
What is Tivic Health Systems revenue for the last year?▼
Tivic Health Systems revenue for the last year amounts to 1.56M USD.
What is Tivic Health Systems net income for the last year?▼
TIVC net income for the last year is -11.31M USD.
How many employees does Tivic Health Systems have?▼
As of September 04, 2026, the company has 52 employees.
In which sector is Tivic Health Systems located?▼
Tivic Health Systems operates in the Health & Wellness sector.
When did Tivic Health Systems complete a stock split?▼
The last stock split for Tivic Health Systems was on March 07, 2025 with a ratio of 1:17.
Where is Tivic Health Systems headquartered?▼
Tivic Health Systems is headquartered in Fremont, United States.